Diabetes cell therapies take evasive action
Elie Dolgin • February 25, 2022
Protective encapsulating devices and gene-editing technologies could obviate the need for antirejection drugs in stem-cell-derived therapies for diabetes.
Continue reading at Nature Biotechnology.
It took nearly 50 years to work out the identity of a caribou-like fossil first discovered by construction workers.
Language model delivers predictions that rival years of lab work.